Christoph Schwarz

Christoph Schwarz

Auto-generated profile, based on publicly available information

Christoph Schwarz

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
GMGeorgios Antonios Margonis
Georgios Antonios Margonis
SBStefan Büttner
Stefan Büttner
NANikolaos Andreatos
Nikolaos Andreatos
YKYuhree Kim
Yuhree Kim
DWDoris Wagner
Doris Wagner
MWMatthew J. Weiss
Matthew J. Weiss
During the past 2 decades, genetic predictors of prognosis have been used with increasing frequency for patients with colorectal liver metastasis (CRLM).1 Several investigators have reported on the prognostic value of somatic mutations in the KRAS (OMIM 190070) in patients with resectable CRLM.2-6 Although only 2 studies had assessed KRAS mutational status as a prognostic factor in the 1990s, at least 14 additional studies have been published since 2000.7,8 A 2015 meta-analysis demonstrated the adverse effect of KRAS mutations on prognosis by pooling survival data from 326 patients with KRAS-mutated tumors.9

10 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CSChristoph Schwarz
Christoph Schwarz
IPImmanuel Plass
Immanuel Plass
FFFabian Fitschek
Fabian Fitschek
APAntonia Punzengruber
Antonia Punzengruber
MMMartina Mittlböck
Martina Mittlböck
KKKlaus Kaczirek
Klaus Kaczirek
Postoperative liver dysfunction remains a major concern following hepatic resection. In order to identify patients who are at risk of developing liver dysfunction, indocyanine green (ICG) clearance has been proposed to predict postoperative liver function. All patients who underwent liver resection at the Medical University Vienna, Austria between 2006 and 2015 with preoperative ICG clearance testing (PDR, R15) were analyzed in this study. Postoperative liver dysfunction was analyzed as defined by the International Study Group of Liver Surgery. Overall, 698 patients (male: 394 (56.4%); female: 304 (43.6%)) with a mean age of 61.3 years (SD: 12.9) were included in this study, including 313 minor liver resections (44.8%) and 385 major liver resections (55.2%). One hundred and seven patients developed postoperative liver dysfunction after liver resection (15.3%). Factors associated with liver dysfunction were: male sex (p = 0.043), major liver resection (p < 0.0001), and preoperative ICG clearance (PDR (p = 0.002) and R15 (p < 0.0001)). Notably ICG clearance was significantly associated with liver dysfunction in minor and major liver resections respectively and remained a predictor upon multivariable analysis. An optimal cut-off for preoperative ICG clearance to accurately predict liver dysfunction was PDR < 19.5%/min and R15 > 5.6%. To the best of our knowledge, this is the largest study analyzing the predictive value of preoperative ICG clearance assessment in patients undergoing liver resection. ICG clearance is useful to identify patients at risk of postoperative liver dysfunction.

16 May 2018 in European Radiology
Verified
Journal Article
Open access
PDF file
UAUlrika Asenbaum
Ulrika Asenbaum
KKKlaus Kaczirek
Klaus Kaczirek
ABAhmed Ba-Ssalamah
Ahmed Ba-Ssalamah
HRHelmut Ringl
Helmut Ringl
CSChristoph Schwarz
Christoph Schwarz
RNRichard Nolz
Richard Nolz
Objectives To compare the value of functional future liver remnant (functFLR) to established clinical and imaging variables in prediction of post-hepatectomy liver failure (PHLF) after major liver resection. Methods This retrospective, cross-sectional study included 62 patients, who underwent gadoxetic acid enhanced MRI and MDCT within 10 weeks prior to resection of ≥ 4 liver segments. Future liver remnant (FLR) was measured in MDCT using semi-automatic software. Relative liver enhancement for each FLR segment was calculated as the ratio of signal intensity of parenchyma before and 20 min after i.v. administration of gadoxetic acid and given as mean (remnantRLE). Established variables included indocyanine green clearance, FLR, proportion of FLR, weight-adapted FLR and remnantRLE. functFLR was calculated as FLR multiplied by remnantRLE and divided by patient’s weight. The association of measured variables and PHLF was tested with univariate and multivariate logistic regression analysis and receiver operator characteristics (ROC) curves compared with the DeLong method. Results Sixteen patients (25.8%) experienced PHLF. Univariate logistic regression identified FLR (p = 0.015), proportion of FLR (p = 0.004), weight-adapted FLR (p = 0.003), remnantRLE (p = 0.002) and functFLR (p = 0.002) to be significantly related to the probability of PHLF. In multivariate logistic regression analysis, a decreased functFLR was independently associated with the probability of PHLF (0.561; p = 0.002). Comparing ROC curves, functFLR showed a significantly higher area under the curve (0.904; p < 0.001) than established variables. Conclusions functFLR seems to be superior to established variables in prediction of PHLF after major liver resection. Key Points • functFLR is a parameter combining volumetric and functional imaging information, derived from MDCT and gadoxetic acid enhanced MRI. • In comparison to other established methods, functFLR is superior in prediction of post-hepatectomy liver failure. • functFLR could help to improve patient selection prior major hepatic surgery.

2 December 2013 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
PDF file
NPNina Pilat
Nina Pilat
AFAndreas M. Farkas
Andreas M. Farkas
BMBenedikt Mahr
Benedikt Mahr
CSChristoph Schwarz
Christoph Schwarz
LULukas Unger
Lukas Unger
TWThomas Wekerle
Thomas Wekerle
Background The mixed chimerism approach induces donor-specific tolerance in both pre-clinical models and clinical pilot trials. However, chronic rejection of heart allografts and acute rejection of skin allografts were observed in some chimeric animals despite persistent hematopoietic chimerism and tolerance toward donor antigens in vitro. We tested whether additional cell therapy with regulatory T cells (Tregs) is able to induce full immunologic tolerance and prevent chronic rejection. Methods We recently developed a murine “Treg bone marrow (BM) transplantation (BMT) protocol” that is devoid of cytoreductive recipient pre-treatment. The protocol consists of a moderate dose of fully mismatched allogeneic donor BM under costimulation blockade, together with polyclonal recipient Tregs and rapamycin. Control groups received BMT under non-myeloablative irradiation and costimulation blockade without Treg therapy. Multilineage chimerism was followed by flow cytometry, and tolerance was assessed by donor-specific skin and heart allografts. Results Durable multilineage chimerism and long-term donor skin and heart allograft survival were successfully achieved with both protocols. Notably, histologic examination of heart allografts at the end of follow-up revealed that chronic rejection is prevented only in chimeras induced with the Treg protocol. Conclusions In a mouse model of mixed chimerism, additional Treg treatment at the time of BMT prevents chronic rejection of heart allografts. As the Treg-chimerism protocol also obviates the need for cytoreductive recipient treatment it improves both efficacy and safety over previous non-myeloablative mixed chimerism regimens. These results may significantly impact the development of protocols for tolerance induction in cardiac transplantation.

1 December 2016 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
CSChristoph Schwarz
Christoph Schwarz
LULukas Unger
Lukas Unger
BMBenedikt Mahr
Benedikt Mahr
KAKlaus Aumayr
Klaus Aumayr
HRHeinz Regele
Heinz Regele
TWThomas Wekerle
Thomas Wekerle
B7.1/2-targeted costimulation blockade (CTLA4 immunoglobulin [CTLA4-Ig]) is available for immunosuppression after kidney transplantation, but its potentially detrimental impact on regulatory T cells (Tregs) is of concern. We investigated the effects of CTLA4-Ig monotherapy in a fully mismatched heart transplant model (BALB/c onto C57BL/6). CTLA4-Ig was injected chronically (on days 0, 4, 14, and 28 and every 4 weeks thereafter) in dosing regimens paralleling clinical use, shown per mouse: low dose (LD), 0.25 mg (≈10 mg/kg body weight); high dose (HD), 1.25 mg (≈50 mg/kg body weight); and very high dose (VHD), 6.25 mg (≈250 mg/kg body weight). Chronic CTLA4-Ig therapy showed dose-dependent efficacy, with the LD regimen prolonging graft survival and with the HD and VHD regimens leading to >95% long-term graft survival and preserved histology. CTLA4-Ig's effect was immunosuppressive rather than tolerogenic because treatment cessation after ≈3 mo led to rejection. FoxP3-positive Tregs were reduced in naïve mice to a similar degree, independent of the CTLA4-Ig dose, but recovered to normal values in heart recipients under chronic CTLA4-Ig therapy. Treg depletion (anti-CD25) resulted in an impaired outcome under LD therapy but had no detectable effect under HD therapy. Consequently, the immunosuppressive effect of partially effective LD CTLA4-Ig therapy is impaired when Tregs are removed, whereas CTLA4-Ig monotherapy at higher doses effectively maintains graft survival independent of Tregs.

18 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CSChristoph Schwarz
Christoph Schwarz
FFFabian Fitschek
Fabian Fitschek
DBDavid Bar-Or
David Bar-Or
DKDaniel A. Klaus
Daniel A. Klaus
BTBianca Tudor
Bianca Tudor
KKKlaus Kaczirek
Klaus Kaczirek
Postoperative complications are still a major concern after liver resection (LR). Systemic inflammation and deregulated reactive oxygen species during major abdominal surgery may impair outcome after hepatectomy. Patients undergoing LR were included in this study (n = 40). Oxidative stress (OS) was measured peri- and post-operatively as static oxidation-reduction potential markers (sORP) and antioxidant capacity ORP (cORP) by using the RedoxSYS Diagnostic system. Furthermore, Th1- and Th2-specific cytokines were assessed. Whereas there was no significant change in systemic sORP during LR and in the early postoperative course, there was a substantial decrease of cORP immediately post-surgery, and on postoperative days 1 and 3 (p<0.001). OS response was tightly regulated, as there was a significant correlation between sORP and cORP (p<0.0001; R2:0.457). An increase of OS (sORP) after LR of more than 3 mV was predictive for severe postoperative complications (53.8% vs. 12.5; p = 0.017). There was a significantly higher IL-2 (p = 0.006) and IL-5 (p = 0.001) increase during hepatectomy in patients who developed a severe morbidity. Antioxidant capacity remained stable during LR but dropped during the post-surgical period, suggesting a consumption of antioxidants to maintain OS within healthy range. Severe postoperative complications were associated with a pronounced inflammatory response during surgery.